Molecular Therapy Journals welcoming articles

0 views
Skip to first unread message

Saumyadip Sarkar

unread,
Jul 12, 2018, 3:13:07 AM7/12/18
to wethemicrobiologist
Can't see this email properly? Click here to view an online version
Molecular TherapyAmerican Society of Gene & Cell Therapy
Special Issue Call for Research Papers:
mRNA Therapy 

Submit your paper before
September 30, 2018
 

Molecular Therapy and Molecular Therapy – Nucleic Acids are pleased to announce a call for papers for their upcoming special issue on the topic of mRNA therapy.

The first therapeutic use of in vitro-transcribed mRNA was reported in 1992. Since then many advances have been made to improve translation, stability, and delivery of the mRNA. Currently, the therapeutic application of mRNA technology has expanded into several areas, including cancer immunotherapies, infectious disease vaccines, protein replacement therapies, genome engineering, and genetic reprogramming. As evidenced in the pages of the Molecular Therapy family and elsewhere, the interest in this therapeutic platform continues to grow. Given this interest, the editors are happy to announce a joint special issue of Molecular Therapy and Molecular Therapy – Nucleic Acids that aims to focus on this important area.

The special issue will be guest edited by Drs. Katalin Karikó and Paloma Giangrande and will comprise eight distinguished topical reviews together with peer-reviewed original research papers. We hereby invite researchers to submit manuscripts, with a deadline of September 30, 2018.

Invited Reviews

  • mRNA Vaccines for Infectious Diseases
    Jeffrey Ulmer
  • mRNA for Cancer Vaccines
    Ugur Sahin
  • mRNA Delivery
    Daniel Anderson
  • mRNA-based Protein Replacement Therapy for the Heart
    Lior Zangi
  • mRNA-based Protein Replacement Therapy for the Lung
    Michael Korman
  • mRNA-based Protein Replacement Therapy for the Liver
    Carsten Rudolph
  • mRNA-based Antibodies
    Thomas Schlake

Submit your paper before
September 30, 2018

Guest Editors

Katalin KarikoKatalin Karikó
BioNTech RNA Pharmaceuticals, 
Germany
 
Paloma GiangrandePaloma Giangrande
University of Iowa, USA

Director of Research, 
Rare Diseases
Moderna Therapeutics

--
Mr. Saumyadip Sarkar
TIGP Molecular and Cell Biology Grad Student (PhD),
Lab 525, Institute of Molecular Biology (IMB)
Academia Sinica, Taipei-115, Taiwan
@iamsaumyadip


Reply all
Reply to author
Forward
0 new messages